Monday, October 12, 2026
20.2 C
Bengaluru

Kailash Joshi has been appointed as Executive Director – Analytics, Insights & Decision Enablement (US) at Novartis, as part of the Novartis Global Capability Center in Hyderabad.

With extensive experience across commercial excellence, analytics, insights, AI-driven decision-making, and healthcare strategy, Kailash brings a strong track record of enabling organizations to leverage data and technology to drive better business outcomes.

In his new role, he will lead a team of professionals and subject matter experts within the Novartis US Analytics, Insights & Decision Enablement organization. His focus will be on harnessing the power of analytics, insights, and emerging technologies to transform data into actionable intelligence and support strategic decision-making.

Kailash returns to Novartis with a wealth of experience in commercial strategy and healthcare transformation. His leadership journey includes driving initiatives across commercial excellence, customer engagement, business intelligence, omnichannel strategy, and capability building.

Free Membership Required

You must be a Free member to access this content.

Join Now

Already a member? Log in here

Hot this week

Who Is Accountable for the Medicine in Your Hand?

The Accountability Gap: India’s Drug Regulatory System Your doctor prescribes...

Who Profits From Trust?

Indian healthcare does not suffer from a shortage of...

The Great Healthcare Dilemma: Who Will Own the Next Indian Hospital?

The next owner of an Indian hospital may not...

Indian Pharma’s Three Deficits—and Three Potential Dividends

Indian pharma has already done the hard thing once. It...

Indian Pharma Is Two Industries Wearing One Label

Indian pharma is often discussed as one sector. In...

Topics

Who Is Accountable for the Medicine in Your Hand?

The Accountability Gap: India’s Drug Regulatory System Your doctor prescribes...

Who Profits From Trust?

Indian healthcare does not suffer from a shortage of...

Indian Pharma Is Two Industries Wearing One Label

Indian pharma is often discussed as one sector. In...

Why Is the World’s Pharmacy Failing to Protect Patients from Harm?

This MedicinMan Intelligence Report follows a disturbing trail—from Arun...
spot_img

Related Articles

spot_imgspot_img